» Articles » PMID: 33052529

Endoscopic Ultrasound-guided Parenchymal Liver Biopsy: a Systematic Review and Meta-analysis

Overview
Journal Surg Endosc
Publisher Springer
Date 2020 Oct 14
PMID 33052529
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endoscopic ultrasonography (EUS)-guided liver biopsy is a novel technique to obtain adequate liver samples for diagnosis of liver parenchymal diseases. There are studies that have evaluated the feasibility and safety of EUS-guided parenchymal liver biopsy (EUS-LB), however, factors that can influence specimen quality are yet to be determined. Our aim was to determine the diagnostic accuracy of EUS-LB and evaluate factors associated with specimen quality.

Methods: We performed a detailed search of PubMed/MEDLINE and Web of Science™ databases to identify studies in which results of EUS-guided liver parenchymal biopsies were reported published up to July 2020. A random effects model was used to estimate pooled values (mean ± SE) for total specimen length (TSL) and complete portal tracts (CPT). Subgroup analyses were applied to find out the procedural factors associated with better specimen quality using Cochran's Q test. A total of 10 meta-analyses were done focusing on international studies. Total of 1326 patients who underwent EUS-LB. EUS-LBs performed for suspicion of parenchymal liver disease. Pooled mean values for TSL and CPT with subgroup analyses.

Results: Twenty-three studies with a total of 1326 patients were included in our meta-analysis. Overall pooled mean TSL and CPT were 45.3 ± 4.6 mm and 15.8 ± 1.5, respectively. In subgroup analysis, core biopsy needles proved to better in terms of CPT than fine-needle aspiration needles (18.4 vs 10.99, p = 0.003). FNB with slow-pull or suction technique provided a similar TSL (44.3 vs 53.9 mm, p = 0.40), however, slow-pull technique was better in terms of CPT (30 vs 14.6, p < 0.001). Heterogeneity was present among the studies. Another limitation is the low number randomized control trials.

Conclusion: EUS-guided parenchymal liver biopsy is a good alternative to other methods of liver sampling. Using FNB needles with a slow-pull technique can provide better results.

Citing Articles

Endo-hepatology: Why should we do endoscopic ultrasound-guided interventions to the liver that we could do through the skin?.

Calvanese C, Fusaroli P World J Gastroenterol. 2024; 30(40):4333-4338.

PMID: 39494095 PMC: 11525869. DOI: 10.3748/wjg.v30.i40.4333.


Distinct ways to perform a liver biopsy: The core technique setups and updated understanding of these modalities.

Sun C, Zhao X, Shi L, Fan X, Qi X Endosc Ultrasound. 2024; 12(6):437-444.

PMID: 38948122 PMC: 11213587. DOI: 10.1097/eus.0000000000000035.


Comparison of diagnostic outcomes, safety, and cost of Franseen-tip 19G versus 22G needles for endoscopic ultrasound-guided liver biopsies.

Dalal A, Kamat N, Patil G, Vadgaonkar A, Parekh S, Vora S Endosc Int Open. 2024; 12(2):E291-E296.

PMID: 38420158 PMC: 10901641. DOI: 10.1055/a-2226-1337.


Clinical value of [F]AlF-NOTA-FAPI-04 PET/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients.

Rao W, Fang X, Zhao Y, Wang Y, Zhang B, Wei Z Jpn J Radiol. 2024; 42(5):536-545.

PMID: 38316724 DOI: 10.1007/s11604-024-01528-0.


Current perspectives on the diversification of endoscopic ultrasound-guided fine-needle aspiration and biopsy.

Doi S, Adachi T, Watanabe A, Katsukura N, Tsujikawa T J Med Ultrason (2001). 2023; 51(2):235-243.

PMID: 38108995 DOI: 10.1007/s10396-023-01393-w.


References
1.
Rockey D, Caldwell S, Goodman Z, Nelson R, Smith A . Liver biopsy. Hepatology. 2009; 49(3):1017-44. DOI: 10.1002/hep.22742. View

2.
Boyum J, Atwell T, Schmit G, Poterucha J, Schleck C, Harmsen W . Incidence and Risk Factors for Adverse Events Related to Image-Guided Liver Biopsy. Mayo Clin Proc. 2016; 91(3):329-35. DOI: 10.1016/j.mayocp.2015.11.015. View

3.
Seeff L, Everson G, Morgan T, Curto T, Lee W, Ghany M . Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010; 8(10):877-83. PMC: 3771318. DOI: 10.1016/j.cgh.2010.03.025. View

4.
Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M . Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. J Hepatol. 2007; 47(2):284-94. DOI: 10.1016/j.jhep.2007.05.001. View

5.
Nguyen P, Feng J, Chang K . Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc. 1999; 50(3):357-61. DOI: 10.1053/ge.1999.v50.97208. View